Heterozygous variants in NOTCH2 in a cohort of juvenile and adult patients with cholestatic liver disease: Disease modifiers or innocent bystanders?
Background and objective: Genetic cholestatic liver diseases are increasingly stratified using NGS. The resulting information can guide treatment with novel drugs such as IBAT inhibitors, which have demonstrated efficacy in congenital liver disorders including Alagille syndrome and PFIC. We hypothesised [for full text, please go to the a.m. URL]
Authors
- R. Liebe
- M. Krawczyk
- H H Schmidt
- F. Lammert
- A. Stalke
Institutions
- Medizinische Hochschule Hannover (DE)
- University of Duisburg-Essen (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2026-06-18
- DOI
- https://doi.org/10.3205/26vzmnrw124
- Primary Topic
- Pediatric Hepatobiliary Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00